Medtronic (NYSE:MDT) Flashes a High-Quality Breakout Setup
Medtronic executives to speak at upcoming investor conferences
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow
UBS Maintains Buy on Medtronic, Raises Price Target to $110
Is Medtronic Stock Underperforming the Dow?
Truist Securities Reiterates Hold on Medtronic, Raises Price Target to $99
Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection
Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $104
RBC Capital Reiterates Outperform on Medtronic, Maintains $118 Price Target
B of A Securities Maintains Buy on Medtronic, Raises Price Target to $110
Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings
Stifel Maintains Hold on Medtronic, Raises Price Target to $95
Baird Maintains Neutral on Medtronic, Raises Price Target to $100
Medtronic Flirts With A Breakout As Its Spinoff, MiniMed, Hits A Record
Medtronic Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
Medtronic's Diabetes Spinoff Just Surged. What To Look For In Its Earnings.
Here's What Key Metrics Tell Us About Medtronic (MDT) Q1 Earnings
Medtronic plc (MDT) Q1 2027 Earnings Call Transcript
Medtronic (MDT) Invests In Pi Cardia For Complex TAVR Procedures
What Medtronic (MDT)'s Cornerstone Robotics Deal Means For Shareholders
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.